肾综合征出血热连续性肾脏替代治疗及肝素抗凝的应用研究

摘要

Objective To study the continuous renal replacement therapy of hemorrhagic fever with renal syndrome and clinical application of heparin anticoagulation. Methods 60 cases of patients with hemorrhagic fever with renal syndrome diagnosed and treated in our hospital from January 2014 to August 2015 were retrospectively analyzed. Results The effec-tive rate of initial and continuous renal replacement therapy of critically severe patients in the overlapping period was obvi-ously higher than that of the severe patients, (50.0%vs 9.0%). Conclusion We should rationally choose whether to use hep-arin anticoagulation or not in the continuous renal replacement therapy according to the characteristics of patients.%目的：探究肾综合征出血热连续性肾脏替代治疗及肝素抗凝的临床应用情况。方法选取在该院2014年1月—2015年8月进行诊治的肾综合征出血热患者60例进行回顾性分析。结果危重型患者重叠期初始连续性肾脏替代治疗的有效率是50.0%，重型为9.0%，危重型患者连续性肾脏替代治疗效果以及重叠期开始连续性肾脏替代治疗明显高于重型。结论连续性肾脏替代治疗需结合患者特点合理选择是否使用肝素抗凝。